|
| 37228396 | Uncovering transcriptomic landscape alterations of CAN-2409 in <i>in vitro</i> and <i>in vivo</i> glioma models. | Front Med (Lausanne) | 2023 |
| 36768186 | Mammalian Glycosylation Patterns Protect Citrullinated Chemokine MCP-1/CCL2 from Partial Degradation. | | 2023 |
| 35017150 | Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models. | J Immunother Cancer | 2022 |
| 36032633 | Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma. | Mol Ther Oncolytics | 2022 |
| 35406668 | Increased Frequency of CD4 Follicular Helper T and CD8 Follicular T Cells in Human Lymph Node Biopsies during the Earliest Stages of Rheumatoid Arthritis. | Cells | 2022 |
| 36477362 | A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome. | | 2022 |
| 34902228 | Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach. | Arthritis Care Res (Hoboken) | 2022 |
| 35203534 | Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis. | Biomedicines | 2022 |
| 34389633 | A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis. | BMJ Open Gastroenterology | 2021 |
| 33968050 | Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints. | Front Immunol | 2021 |
| 33726834 | A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis. | | 2021 |
| 34675389 | Immune-mediated inflammation across disease boundaries: breaking down research silos. | Nature Immunology | 2021 |
| 31377797 | Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients. | Rheumatology | 2020 |
| 32094157 | Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM). | Annals of the Rheumatic Diseases | 2020 |
| 33015599 | cDC1 are required for the initiation of collagen-induced arthritis. | Journal of Translational Autoimmunity | 2020 |
| 32784936 | Human Lymph Node Stromal Cells Have the Machinery to Regulate Peripheral Tolerance during Health and Rheumatoid Arthritis. | International Journal of Molecular Sciences | 2020 |
| 31474600 | Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA. | Journal of Rheumatology | 2020 |
| 31330824 | Myeloid Dendritic Cells Are Enriched in Lymph Node Tissue of Early Rheumatoid Arthritis Patients but not in At Risk Individuals. | Cells | 2019 |
| 30504445 | Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. | Annals of the Rheumatic Diseases | 2019 |
| 30420245 | Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis. | Semin Arthritis Rheum | 2019 |
| 30649469 | Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis. | Rheumatology | 2019 |
| 31481955 | Molecular Characterization of Human Lymph Node Stromal Cells During the Earliest Phases of Rheumatoid Arthritis. | Frontiers in Immunology | 2019 |
| 31217169 | Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire. | Annals of the Rheumatic Diseases | 2019 |
| 31068673 | Therapeutic options for targeting inflammatory osteoarthritis pain. | Nature reviews. Rheumatology | 2019 |
| 30898822 | Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol. | BMJ Open | 2019 |
| 29795407 | Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients. | Pharmacogenomics J | 2018 |
| 28389989 | Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolism. | Clinical Rheumatology | 2018 |
| 30155621 | Fibroblasts and Osteoblasts in Inflammation and Bone Damage. | Advances in Experimental Medicine and Biology | 2018 |
| 30092827 | Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial. | | 2018 |
| 29907666 | Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study. | J Rheumatol | 2018 |
| 29483080 | Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study. | Annals of the Rheumatic Diseases | 2018 |
| 29482663 | Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis. | Arthritis Res Ther | 2018 |
| 29379035 | Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering. | Sci Rep | 2018 |
| 29471421 | Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytes. | Rheumatology | 2018 |
| 29587639 | MiR-146a G/C rs2910164 variation in South African Indian and Caucasian patients with psoriatic arthritis. | BMC Medical Genetics | 2018 |
| 28128853 | Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis. | Clin Exp Immunol | 2017 |
| 28690611 | Insight into the Endocrine System and the Immune System: A Review of the Inflammatory Role of Prolactin in Rheumatoid Arthritis and Psoriatic Arthritis. | Frontiers in Immunology | 2017 |
| 28688467 | Prediction of Response to Targeted Treatment in Rheumatoid Arthritis. | Mayo Clinic Proceedings | 2017 |
| 28642278 | Rheumatoid arthritis and psoriatic arthritis synovial fluids stimulate prolactin production by macrophages. | Journal of Leukocyte Biology | 2017 |
| 28855173 | Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study. | Annals of the Rheumatic Diseases | 2017 |
| 28547815 | Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. | Journal of Internal Medicine | 2017 |
| 28935945 | Synovial tissue research: a state-of-the-art review. | Nature reviews. Rheumatology | 2017 |
| 28793332 | Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis. | PLoS ONE | 2017 |
| 28790026 | Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis. | Annals of the Rheumatic Diseases | 2017 |
| 28701760 | Synovial tissue research: a state-of-the-art review. | Nature reviews. Rheumatology | 2017 |
| 28321219 | Computational Model Reveals Limited Correlation between Germinal Center B-Cell Subclone Abundancy and Affinity: Implications for Repertoire Sequencing. | Frontiers in Immunology | 2017 |
| 29255214 | Corrigendum: Synovial tissue research: a state-of-the-art review. | Nature reviews. Rheumatology | 2017 |
| 27428460 | Brief Report: Altered Innate Lymphoid Cell Subsets in Human Lymph Node Biopsy Specimens Obtained During the At-Risk and Earliest Phases of Rheumatoid Arthritis. | Arthritis Rheumatol | 2017 |
| 27457515 | Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes. | Annals of the Rheumatic Diseases | 2017 |
| 27807638 | Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease. | Clinical Rheumatology | 2017 |